Finding 1219543 (2025-001)

Material Weakness Repeat Finding
Requirement
I
Questioned Costs
-
Year
2025
Accepted
2026-06-26

AI Summary

  • Core Issue: The Medical Center failed to evaluate all vendors for suspension and debarment, risking noncompliance with federal procurement regulations.
  • Impacted Requirements: This finding relates to 2 CFR Section 200.303 and 200.214, which mandate effective internal controls and compliance with suspension and debarment regulations.
  • Recommended Follow-Up: Management should enhance internal controls to ensure all vendors are evaluated for suspension and debarment before transactions, with proper documentation and monitoring in place.

Finding Text

Finding 2025-001- Material Weakness related to Procurement and Suspension and Debarment Identification of the Federal Program Federal Agency: Department of Health and Human Services, Department of Homeland Security, Department of Defense, Department of Justice, National Science Foundation, Department of Agriculture, US Agency for International Development Program Name: Research and Development Cluster Assistance Listing Number: Various Criteria or Specific Requirement: 2 CFR Section 200.303 of the Uniform Guidance states the following regarding internal control: “The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” 2 CFR Section 200.214 – Suspension and debarment – Non-Federal entities are subject to the non-procurement debarment and suspension regulations that restrict awards, subawards, and contracts with certain parties that are debarred, suspended, or otherwise excluded from or ineligible for participation in Federal assistance programs or activities. Condition: The Medical Center did not evaluate all vendors for suspension and debarment during the fiscal year. As a result, there were instances of procurement transactions where the vendor was not subjected to suspension and debarment evaluation procedures prior to entering into the transaction. Cause: The issue occurred due to deficiencies in the design and operation of controls over the completeness and accuracy of vendor information provided to the third-party service provider for suspension and debarment monitoring. Specifically, controls were not in place to ensure that all vendors used for the Research and Development Cluster program expenditures were included in the vendor listing submitted for suspension and debarment monitoring. Effect or Potential Effect: The lack of an effective control over suspension and debarment has the potential to result in noncompliance with applicable requirements. Accordingly, the Medical Center could have entered into a procurement transaction with a suspended or debarred vendor. Questioned Costs: No questioned costs were identified. Context: Management was unable to provide evidence of a control being consistently performed throughout the audit period. The total population consisted of 1,374 vendors utilized for expenditures charged to the Research and Development Cluster. Our testing identified that 844 vendors, representing approximately $80 million in expenditures, were not evaluated for suspension and debarment prior to entering into a transaction. The remaining 530 vendors were appropriately evaluated. Subsequently, all 1,374 vendors were evaluated for suspension and debarment and none were noted as being suspended or debarred. Identification as a Repeat Finding: Not a repeat finding. Recommendation: Management should design and implement effective internal controls to ensure the completeness and accuracy of vendor listings submitted for suspension and debarment evaluation. Controls should include procedures to verify that all vendors associated with Federal program expenditures are evaluated prior to entering into transactions and that evaluation results are appropriately documented and monitored on an ongoing basis. Views of Responsible Officials: Management concurs with the finding and has implemented procedures to ensure the vendor list for suspension and debarment evaluation is complete and accurate.

Corrective Action Plan

Finding 2025-001- Material Weakness related to Procurement and Suspension and Debarment Information on the federal program: Federal Agency: Department of Health and Human Services, Department of Homeland Security, Department of Defense, Department of Justice, National Science Foundation, Department of Agriculture, US Agency for International Development Program Name: Research and Development Cluster Assistance Listing Number: Various Planned corrective action: The Medical Center has updated the reporting logic of the vendor report submitted to the third-party service provider for suspension and debarment evaluation. The Medical Center has also implemented an internal control where a member of Research Finance management will review the vendor report for accuracy and completeness and sign-off prior to submitting to the third-party service provider for suspension and debarment evaluation. Name of responsible official: Michael Brennan Director, Research Finance Michael.Brennan@childrens.harvard.edu Anticipated completion date: May 11, 2026

Categories

Procurement, Suspension & Debarment Subrecipient Monitoring

Other Findings in this Audit

  • 1219177 2025-001
    Material Weakness Repeat
  • 1219178 2025-001
    Material Weakness Repeat
  • 1219179 2025-001
    Material Weakness Repeat
  • 1219180 2025-001
    Material Weakness Repeat
  • 1219181 2025-001
    Material Weakness Repeat
  • 1219182 2025-001
    Material Weakness Repeat
  • 1219183 2025-001
    Material Weakness Repeat
  • 1219184 2025-001
    Material Weakness Repeat
  • 1219185 2025-001
    Material Weakness Repeat
  • 1219186 2025-001
    Material Weakness Repeat
  • 1219187 2025-001
    Material Weakness Repeat
  • 1219188 2025-001
    Material Weakness Repeat
  • 1219189 2025-001
    Material Weakness Repeat
  • 1219190 2025-001
    Material Weakness Repeat
  • 1219191 2025-001
    Material Weakness Repeat
  • 1219192 2025-001
    Material Weakness Repeat
  • 1219193 2025-001
    Material Weakness Repeat
  • 1219194 2025-001
    Material Weakness Repeat
  • 1219195 2025-001
    Material Weakness Repeat
  • 1219196 2025-001
    Material Weakness Repeat
  • 1219197 2025-001
    Material Weakness Repeat
  • 1219198 2025-001
    Material Weakness Repeat
  • 1219199 2025-001
    Material Weakness Repeat
  • 1219200 2025-001
    Material Weakness Repeat
  • 1219201 2025-001
    Material Weakness Repeat
  • 1219202 2025-001
    Material Weakness Repeat
  • 1219203 2025-001
    Material Weakness Repeat
  • 1219204 2025-001
    Material Weakness Repeat
  • 1219205 2025-001
    Material Weakness Repeat
  • 1219206 2025-001
    Material Weakness Repeat
  • 1219207 2025-001
    Material Weakness Repeat
  • 1219208 2025-001
    Material Weakness Repeat
  • 1219209 2025-001
    Material Weakness Repeat
  • 1219210 2025-001
    Material Weakness Repeat
  • 1219211 2025-001
    Material Weakness Repeat
  • 1219212 2025-001
    Material Weakness Repeat
  • 1219213 2025-001
    Material Weakness Repeat
  • 1219214 2025-001
    Material Weakness Repeat
  • 1219215 2025-001
    Material Weakness Repeat
  • 1219216 2025-001
    Material Weakness Repeat
  • 1219217 2025-001
    Material Weakness Repeat
  • 1219218 2025-001
    Material Weakness Repeat
  • 1219219 2025-001
    Material Weakness Repeat
  • 1219220 2025-001
    Material Weakness Repeat
  • 1219221 2025-001
    Material Weakness Repeat
  • 1219222 2025-001
    Material Weakness Repeat
  • 1219223 2025-001
    Material Weakness Repeat
  • 1219224 2025-001
    Material Weakness Repeat
  • 1219225 2025-001
    Material Weakness Repeat
  • 1219226 2025-001
    Material Weakness Repeat
  • 1219227 2025-001
    Material Weakness Repeat
  • 1219228 2025-001
    Material Weakness Repeat
  • 1219229 2025-001
    Material Weakness Repeat
  • 1219230 2025-001
    Material Weakness Repeat
  • 1219231 2025-001
    Material Weakness Repeat
  • 1219232 2025-001
    Material Weakness Repeat
  • 1219233 2025-001
    Material Weakness Repeat
  • 1219234 2025-001
    Material Weakness Repeat
  • 1219235 2025-001
    Material Weakness Repeat
  • 1219236 2025-001
    Material Weakness Repeat
  • 1219237 2025-001
    Material Weakness Repeat
  • 1219238 2025-001
    Material Weakness Repeat
  • 1219239 2025-001
    Material Weakness Repeat
  • 1219240 2025-001
    Material Weakness Repeat
  • 1219241 2025-001
    Material Weakness Repeat
  • 1219242 2025-001
    Material Weakness Repeat
  • 1219243 2025-001
    Material Weakness Repeat
  • 1219244 2025-001
    Material Weakness Repeat
  • 1219245 2025-001
    Material Weakness Repeat
  • 1219246 2025-001
    Material Weakness Repeat
  • 1219247 2025-001
    Material Weakness Repeat
  • 1219248 2025-001
    Material Weakness Repeat
  • 1219249 2025-001
    Material Weakness Repeat
  • 1219250 2025-001
    Material Weakness Repeat
  • 1219251 2025-001
    Material Weakness Repeat
  • 1219252 2025-001
    Material Weakness Repeat
  • 1219253 2025-001
    Material Weakness Repeat
  • 1219254 2025-001
    Material Weakness Repeat
  • 1219255 2025-001
    Material Weakness Repeat
  • 1219256 2025-001
    Material Weakness Repeat
  • 1219257 2025-001
    Material Weakness Repeat
  • 1219258 2025-001
    Material Weakness Repeat
  • 1219259 2025-001
    Material Weakness Repeat
  • 1219260 2025-001
    Material Weakness Repeat
  • 1219261 2025-001
    Material Weakness Repeat
  • 1219262 2025-001
    Material Weakness Repeat
  • 1219263 2025-001
    Material Weakness Repeat
  • 1219264 2025-001
    Material Weakness Repeat
  • 1219265 2025-001
    Material Weakness Repeat
  • 1219266 2025-001
    Material Weakness Repeat
  • 1219267 2025-001
    Material Weakness Repeat
  • 1219268 2025-001
    Material Weakness Repeat
  • 1219269 2025-001
    Material Weakness Repeat
  • 1219270 2025-001
    Material Weakness Repeat
  • 1219271 2025-001
    Material Weakness Repeat
  • 1219272 2025-001
    Material Weakness Repeat
  • 1219273 2025-001
    Material Weakness Repeat
  • 1219274 2025-001
    Material Weakness Repeat
  • 1219275 2025-001
    Material Weakness Repeat
  • 1219276 2025-001
    Material Weakness Repeat
  • 1219277 2025-001
    Material Weakness Repeat
  • 1219278 2025-001
    Material Weakness Repeat
  • 1219279 2025-001
    Material Weakness Repeat
  • 1219280 2025-001
    Material Weakness Repeat
  • 1219281 2025-001
    Material Weakness Repeat
  • 1219282 2025-001
    Material Weakness Repeat
  • 1219283 2025-001
    Material Weakness Repeat
  • 1219284 2025-001
    Material Weakness Repeat
  • 1219285 2025-001
    Material Weakness Repeat
  • 1219286 2025-001
    Material Weakness Repeat
  • 1219287 2025-001
    Material Weakness Repeat
  • 1219288 2025-001
    Material Weakness Repeat
  • 1219289 2025-001
    Material Weakness Repeat
  • 1219290 2025-001
    Material Weakness Repeat
  • 1219291 2025-001
    Material Weakness Repeat
  • 1219292 2025-001
    Material Weakness Repeat
  • 1219293 2025-001
    Material Weakness Repeat
  • 1219294 2025-001
    Material Weakness Repeat
  • 1219295 2025-001
    Material Weakness Repeat
  • 1219296 2025-001
    Material Weakness Repeat
  • 1219297 2025-001
    Material Weakness Repeat
  • 1219298 2025-001
    Material Weakness Repeat
  • 1219299 2025-001
    Material Weakness Repeat
  • 1219300 2025-001
    Material Weakness Repeat
  • 1219301 2025-001
    Material Weakness Repeat
  • 1219302 2025-001
    Material Weakness Repeat
  • 1219303 2025-001
    Material Weakness Repeat
  • 1219304 2025-001
    Material Weakness Repeat
  • 1219305 2025-001
    Material Weakness Repeat
  • 1219306 2025-001
    Material Weakness Repeat
  • 1219307 2025-001
    Material Weakness Repeat
  • 1219308 2025-001
    Material Weakness Repeat
  • 1219309 2025-001
    Material Weakness Repeat
  • 1219310 2025-001
    Material Weakness Repeat
  • 1219311 2025-001
    Material Weakness Repeat
  • 1219312 2025-001
    Material Weakness Repeat
  • 1219313 2025-001
    Material Weakness Repeat
  • 1219314 2025-001
    Material Weakness Repeat
  • 1219315 2025-001
    Material Weakness Repeat
  • 1219316 2025-001
    Material Weakness Repeat
  • 1219317 2025-001
    Material Weakness Repeat
  • 1219318 2025-001
    Material Weakness Repeat
  • 1219319 2025-001
    Material Weakness Repeat
  • 1219320 2025-001
    Material Weakness Repeat
  • 1219321 2025-001
    Material Weakness Repeat
  • 1219322 2025-001
    Material Weakness Repeat
  • 1219323 2025-001
    Material Weakness Repeat
  • 1219324 2025-001
    Material Weakness Repeat
  • 1219325 2025-001
    Material Weakness Repeat
  • 1219326 2025-001
    Material Weakness Repeat
  • 1219327 2025-001
    Material Weakness Repeat
  • 1219328 2025-001
    Material Weakness Repeat
  • 1219329 2025-001
    Material Weakness Repeat
  • 1219330 2025-001
    Material Weakness Repeat
  • 1219331 2025-001
    Material Weakness Repeat
  • 1219332 2025-001
    Material Weakness Repeat
  • 1219333 2025-001
    Material Weakness Repeat
  • 1219334 2025-001
    Material Weakness Repeat
  • 1219335 2025-001
    Material Weakness Repeat
  • 1219336 2025-001
    Material Weakness Repeat
  • 1219337 2025-001
    Material Weakness Repeat
  • 1219338 2025-001
    Material Weakness Repeat
  • 1219339 2025-001
    Material Weakness Repeat
  • 1219340 2025-001
    Material Weakness Repeat
  • 1219341 2025-001
    Material Weakness Repeat
  • 1219342 2025-001
    Material Weakness Repeat
  • 1219343 2025-001
    Material Weakness Repeat
  • 1219344 2025-001
    Material Weakness Repeat
  • 1219345 2025-001
    Material Weakness Repeat
  • 1219346 2025-001
    Material Weakness Repeat
  • 1219347 2025-001
    Material Weakness Repeat
  • 1219348 2025-001
    Material Weakness Repeat
  • 1219349 2025-001
    Material Weakness Repeat
  • 1219350 2025-001
    Material Weakness Repeat
  • 1219351 2025-001
    Material Weakness Repeat
  • 1219352 2025-001
    Material Weakness Repeat
  • 1219353 2025-001
    Material Weakness Repeat
  • 1219354 2025-001
    Material Weakness Repeat
  • 1219355 2025-001
    Material Weakness Repeat
  • 1219356 2025-001
    Material Weakness Repeat
  • 1219357 2025-001
    Material Weakness Repeat
  • 1219358 2025-001
    Material Weakness Repeat
  • 1219359 2025-001
    Material Weakness Repeat
  • 1219360 2025-001
    Material Weakness Repeat
  • 1219361 2025-001
    Material Weakness Repeat
  • 1219362 2025-001
    Material Weakness Repeat
  • 1219363 2025-001
    Material Weakness Repeat
  • 1219364 2025-001
    Material Weakness Repeat
  • 1219365 2025-001
    Material Weakness Repeat
  • 1219366 2025-001
    Material Weakness Repeat
  • 1219367 2025-001
    Material Weakness Repeat
  • 1219368 2025-001
    Material Weakness Repeat
  • 1219369 2025-001
    Material Weakness Repeat
  • 1219370 2025-001
    Material Weakness Repeat
  • 1219371 2025-001
    Material Weakness Repeat
  • 1219372 2025-001
    Material Weakness Repeat
  • 1219373 2025-001
    Material Weakness Repeat
  • 1219374 2025-001
    Material Weakness Repeat
  • 1219375 2025-001
    Material Weakness Repeat
  • 1219376 2025-001
    Material Weakness Repeat
  • 1219377 2025-001
    Material Weakness Repeat
  • 1219378 2025-001
    Material Weakness Repeat
  • 1219379 2025-001
    Material Weakness Repeat
  • 1219380 2025-001
    Material Weakness Repeat
  • 1219381 2025-001
    Material Weakness Repeat
  • 1219382 2025-001
    Material Weakness Repeat
  • 1219383 2025-001
    Material Weakness Repeat
  • 1219384 2025-001
    Material Weakness Repeat
  • 1219385 2025-001
    Material Weakness Repeat
  • 1219386 2025-001
    Material Weakness Repeat
  • 1219387 2025-001
    Material Weakness Repeat
  • 1219388 2025-001
    Material Weakness Repeat
  • 1219389 2025-001
    Material Weakness Repeat
  • 1219390 2025-001
    Material Weakness Repeat
  • 1219391 2025-001
    Material Weakness Repeat
  • 1219392 2025-001
    Material Weakness Repeat
  • 1219393 2025-001
    Material Weakness Repeat
  • 1219394 2025-001
    Material Weakness Repeat
  • 1219395 2025-001
    Material Weakness Repeat
  • 1219396 2025-001
    Material Weakness Repeat
  • 1219397 2025-001
    Material Weakness Repeat
  • 1219398 2025-001
    Material Weakness Repeat
  • 1219399 2025-001
    Material Weakness Repeat
  • 1219400 2025-001
    Material Weakness Repeat
  • 1219401 2025-001
    Material Weakness Repeat
  • 1219402 2025-001
    Material Weakness Repeat
  • 1219403 2025-001
    Material Weakness Repeat
  • 1219404 2025-001
    Material Weakness Repeat
  • 1219405 2025-001
    Material Weakness Repeat
  • 1219406 2025-001
    Material Weakness Repeat
  • 1219407 2025-001
    Material Weakness Repeat
  • 1219408 2025-001
    Material Weakness Repeat
  • 1219409 2025-001
    Material Weakness Repeat
  • 1219410 2025-001
    Material Weakness Repeat
  • 1219411 2025-001
    Material Weakness Repeat
  • 1219412 2025-001
    Material Weakness Repeat
  • 1219413 2025-001
    Material Weakness Repeat
  • 1219414 2025-001
    Material Weakness Repeat
  • 1219415 2025-001
    Material Weakness Repeat
  • 1219416 2025-001
    Material Weakness Repeat
  • 1219417 2025-001
    Material Weakness Repeat
  • 1219418 2025-001
    Material Weakness Repeat
  • 1219419 2025-001
    Material Weakness Repeat
  • 1219420 2025-001
    Material Weakness Repeat
  • 1219421 2025-001
    Material Weakness Repeat
  • 1219422 2025-001
    Material Weakness Repeat
  • 1219423 2025-001
    Material Weakness Repeat
  • 1219424 2025-001
    Material Weakness Repeat
  • 1219425 2025-001
    Material Weakness Repeat
  • 1219426 2025-001
    Material Weakness Repeat
  • 1219427 2025-001
    Material Weakness Repeat
  • 1219428 2025-001
    Material Weakness Repeat
  • 1219429 2025-001
    Material Weakness Repeat
  • 1219430 2025-001
    Material Weakness Repeat
  • 1219431 2025-001
    Material Weakness Repeat
  • 1219432 2025-001
    Material Weakness Repeat
  • 1219433 2025-001
    Material Weakness Repeat
  • 1219434 2025-001
    Material Weakness Repeat
  • 1219435 2025-001
    Material Weakness Repeat
  • 1219436 2025-001
    Material Weakness Repeat
  • 1219437 2025-001
    Material Weakness Repeat
  • 1219438 2025-001
    Material Weakness Repeat
  • 1219439 2025-001
    Material Weakness Repeat
  • 1219440 2025-001
    Material Weakness Repeat
  • 1219441 2025-001
    Material Weakness Repeat
  • 1219442 2025-001
    Material Weakness Repeat
  • 1219443 2025-001
    Material Weakness Repeat
  • 1219444 2025-001
    Material Weakness Repeat
  • 1219445 2025-001
    Material Weakness Repeat
  • 1219446 2025-001
    Material Weakness Repeat
  • 1219447 2025-001
    Material Weakness Repeat
  • 1219448 2025-001
    Material Weakness Repeat
  • 1219449 2025-001
    Material Weakness Repeat
  • 1219450 2025-001
    Material Weakness Repeat
  • 1219451 2025-001
    Material Weakness Repeat
  • 1219452 2025-001
    Material Weakness Repeat
  • 1219453 2025-001
    Material Weakness Repeat
  • 1219454 2025-001
    Material Weakness Repeat
  • 1219455 2025-001
    Material Weakness Repeat
  • 1219456 2025-001
    Material Weakness Repeat
  • 1219457 2025-001
    Material Weakness Repeat
  • 1219458 2025-001
    Material Weakness Repeat
  • 1219459 2025-001
    Material Weakness Repeat
  • 1219460 2025-001
    Material Weakness Repeat
  • 1219461 2025-001
    Material Weakness Repeat
  • 1219462 2025-001
    Material Weakness Repeat
  • 1219463 2025-001
    Material Weakness Repeat
  • 1219464 2025-001
    Material Weakness Repeat
  • 1219465 2025-001
    Material Weakness Repeat
  • 1219466 2025-001
    Material Weakness Repeat
  • 1219467 2025-001
    Material Weakness Repeat
  • 1219468 2025-001
    Material Weakness Repeat
  • 1219469 2025-001
    Material Weakness Repeat
  • 1219470 2025-001
    Material Weakness Repeat
  • 1219471 2025-001
    Material Weakness Repeat
  • 1219472 2025-001
    Material Weakness Repeat
  • 1219473 2025-001
    Material Weakness Repeat
  • 1219474 2025-001
    Material Weakness Repeat
  • 1219475 2025-001
    Material Weakness Repeat
  • 1219476 2025-001
    Material Weakness Repeat
  • 1219477 2025-001
    Material Weakness Repeat
  • 1219478 2025-001
    Material Weakness Repeat
  • 1219479 2025-001
    Material Weakness Repeat
  • 1219480 2025-001
    Material Weakness Repeat
  • 1219481 2025-001
    Material Weakness Repeat
  • 1219482 2025-001
    Material Weakness Repeat
  • 1219483 2025-001
    Material Weakness Repeat
  • 1219484 2025-001
    Material Weakness Repeat
  • 1219485 2025-001
    Material Weakness Repeat
  • 1219486 2025-001
    Material Weakness Repeat
  • 1219487 2025-001
    Material Weakness Repeat
  • 1219488 2025-001
    Material Weakness Repeat
  • 1219489 2025-001
    Material Weakness Repeat
  • 1219490 2025-001
    Material Weakness Repeat
  • 1219491 2025-001
    Material Weakness Repeat
  • 1219492 2025-001
    Material Weakness Repeat
  • 1219493 2025-001
    Material Weakness Repeat
  • 1219494 2025-001
    Material Weakness Repeat
  • 1219495 2025-001
    Material Weakness Repeat
  • 1219496 2025-001
    Material Weakness Repeat
  • 1219497 2025-001
    Material Weakness Repeat
  • 1219498 2025-001
    Material Weakness Repeat
  • 1219499 2025-001
    Material Weakness Repeat
  • 1219500 2025-001
    Material Weakness Repeat
  • 1219501 2025-001
    Material Weakness Repeat
  • 1219502 2025-001
    Material Weakness Repeat
  • 1219503 2025-001
    Material Weakness Repeat
  • 1219504 2025-001
    Material Weakness Repeat
  • 1219505 2025-001
    Material Weakness Repeat
  • 1219506 2025-001
    Material Weakness Repeat
  • 1219507 2025-001
    Material Weakness Repeat
  • 1219508 2025-001
    Material Weakness Repeat
  • 1219509 2025-001
    Material Weakness Repeat
  • 1219510 2025-001
    Material Weakness Repeat
  • 1219511 2025-001
    Material Weakness Repeat
  • 1219512 2025-001
    Material Weakness Repeat
  • 1219513 2025-001
    Material Weakness Repeat
  • 1219514 2025-001
    Material Weakness Repeat
  • 1219515 2025-001
    Material Weakness Repeat
  • 1219516 2025-001
    Material Weakness Repeat
  • 1219517 2025-001
    Material Weakness Repeat
  • 1219518 2025-001
    Material Weakness Repeat
  • 1219519 2025-001
    Material Weakness Repeat
  • 1219520 2025-001
    Material Weakness Repeat
  • 1219521 2025-001
    Material Weakness Repeat
  • 1219522 2025-001
    Material Weakness Repeat
  • 1219523 2025-001
    Material Weakness Repeat
  • 1219524 2025-001
    Material Weakness Repeat
  • 1219525 2025-001
    Material Weakness Repeat
  • 1219526 2025-001
    Material Weakness Repeat
  • 1219527 2025-001
    Material Weakness Repeat
  • 1219528 2025-001
    Material Weakness Repeat
  • 1219529 2025-001
    Material Weakness Repeat
  • 1219530 2025-001
    Material Weakness Repeat
  • 1219531 2025-001
    Material Weakness Repeat
  • 1219532 2025-001
    Material Weakness Repeat
  • 1219533 2025-001
    Material Weakness Repeat
  • 1219534 2025-001
    Material Weakness Repeat
  • 1219535 2025-001
    Material Weakness Repeat
  • 1219536 2025-001
    Material Weakness Repeat
  • 1219537 2025-001
    Material Weakness Repeat
  • 1219538 2025-001
    Material Weakness Repeat
  • 1219539 2025-001
    Material Weakness Repeat
  • 1219540 2025-001
    Material Weakness Repeat
  • 1219541 2025-001
    Material Weakness Repeat
  • 1219542 2025-001
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.879 MEDICAL LIBRARY ASSISTANCE $1.98M
93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS $1.34M
93.U01 DHHS/NIH CONTRACTS $1.21M
93.242 MENTAL HEALTH RESEARCH GRANTS $1.09M
93.253 POISON CENTER SUPPORT AND ENHANCEMENT GRANT $1.05M
93.RD DHHS/NIH CONTRACTS $851,137
93.994 MATERNAL AND CHILD HEALTH SERVICES BLOCK GRANT TO THE STATES $753,610
93.732 MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING GRANTS $638,955
93.632 UNIVERSITY CENTERS FOR EXCELLENCE IN DEVELOPMENTAL DISABILITIES EDUCATION, RESEARCH, AND SERVICE $603,687
93.839 BLOOD DISEASES AND RESOURCES RESEARCH $530,222
93.575 CHILD CARE AND DEVELOPMENT BLOCK GRANT $468,584
93.225 NATIONAL RESEARCH SERVICE AWARDS HEALTH SERVICES RESEARCH TRAINING $461,115
93.384 ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) $410,711
93.345 LEADING EDGE ACCELERATION PROJECTS (LEAP) IN HEALTH INFORMATION TECHNOLOGY $392,173
93.233 NATIONAL CENTER ON SLEEP DISORDERS RESEARCH $378,946
93.283 CENTERS FOR DISEASE CONTROL AND PREVENTION INVESTIGATIONS AND TECHNICAL ASSISTANCE $332,446
93.686 ENDING THE HIV EPIDEMIC: A PLAN FOR AMERICA €” RYAN WHITE HIV/AIDS PROGRAM PARTS A AND B $329,095
47.074 BIOLOGICAL SCIENCES $325,088
12.910 RESEARCH AND TECHNOLOGY DEVELOPMENT $320,868
93.069 PUBLIC HEALTH EMERGENCY PREPAREDNESS $319,245
47.083 INTEGRATIVE ACTIVITIES $286,119
93.213 RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH $269,422
93.395 CANCER TREATMENT RESEARCH $268,312
93.393 CANCER CAUSE AND PREVENTION RESEARCH $267,991
93.080 BLOOD DISORDER PROGRAM: PREVENTION, SURVEILLANCE, AND RESEARCH $263,797
47.070 COMPUTER AND INFORMATION SCIENCE AND ENGINEERING $246,570
93.077 FAMILY SMOKING PREVENTION AND TOBACCO CONTROL ACT REGULATORY RESEARCH $207,144
93.398 CANCER RESEARCH MANPOWER $205,275
93.217 FAMILY PLANNING SERVICES $195,410
47.084 TECHNOLOGY, INNOVATION, AND PARTNERSHIPS $195,158
47.076 STEM EDUCATION (FORMERLY EDUCATION AND HUMAN RESOURCES) $151,041
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $146,125
93.153 COORDINATED SERVICES AND ACCESS TO RESEARCH FOR WOMEN, INFANTS, CHILDREN, AND YOUTH $139,501
16.560 NATIONAL INSTITUTE OF JUSTICE RESEARCH, EVALUATION, AND DEVELOPMENT PROJECT GRANTS $128,570
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $128,314
93.867 VISION RESEARCH $118,680
12.300 BASIC AND APPLIED SCIENTIFIC RESEARCH $109,009
93.068 CHRONIC DISEASES: RESEARCH, CONTROL, AND PREVENTION $104,457
97.061 CENTERS FOR HOMELAND SECURITY $98,901
93.315 RARE DISORDERS: RESEARCH, SURVEILLANCE, HEALTH PROMOTION, AND EDUCATION $80,134
93.U03 DHHS/NIH CONTRACTS $77,573
93.838 LUNG DISEASES RESEARCH $75,403
93.877 AUTISM COLLABORATION, ACCOUNTABILITY, RESEARCH, EDUCATION, AND SUPPORT $74,432
93.643 CHILDREN'S JUSTICE GRANTS TO STATES $71,089
93.351 RESEARCH INFRASTRUCTURE PROGRAMS $65,283
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $64,623
93.396 CANCER BIOLOGY RESEARCH $63,372
93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS $62,935
93.173 RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS $60,798
93.989 INTERNATIONAL RESEARCH AND RESEARCH TRAINING $60,383
93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH $58,900
93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH $58,122
93.113 ENVIRONMENTAL HEALTH $51,942
93.914 HIV EMERGENCY RELIEF PROJECT GRANTS $51,573
93.397 CANCER CENTERS SUPPORT GRANTS $49,453
47.075 SOCIAL, BEHAVIORAL, AND ECONOMIC SCIENCES $47,906
93.576 REFUGEE AND ENTRANT ASSISTANCE DISCRETIONARY GRANTS $47,148
93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH $46,726
93.143 NIEHS SUPERFUND HAZARDOUS SUBSTANCES_BASIC RESEARCH AND EDUCATION $43,735
93.872 TRIBAL MATERNAL, INFANT, AND EARLY CHILDHOOD HOME VISITING $34,437
93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH $34,376
93.172 HUMAN GENOME RESEARCH $33,152
93.U02 DHHS/NIH CONTRACTS $24,612
97.132 FINANCIAL ASSISTANCE FOR TARGETED VIOLENCE AND TERRORISM PREVENTION $23,522
93.127 EMERGENCY MEDICAL SERVICES FOR CHILDREN $22,792
12.RD DOD CONTRACTS $20,765
93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT $18,166
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $17,979
93.421 STRENGTHENING PUBLIC HEALTH SYSTEMS AND SERVICES THROUGH NATIONAL PARTNERSHIPS TO IMPROVE AND PROTECT THE NATION€™S HEALTH $17,781
93.837 CARDIOVASCULAR DISEASES RESEARCH $17,678
93.161 HEALTH PROGRAM FOR TOXIC SUBSTANCES AND DISEASE REGISTRY $17,343
93.197 CHILDHOOD LEAD POISONING PREVENTION PROJECTS, STATE AND LOCAL CHILDHOOD LEAD POISONING PREVENTION AND SURVEILLANCE OF BLOOD LEAD LEVELS IN CHILDREN $16,284
93.273 ALCOHOL RESEARCH PROGRAMS $14,105
93.399 CANCER CONTROL $13,480
93.243 SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $13,313
93.361 NURSING RESEARCH $11,563
97.108 PUBLIC SAFETY AND VIOLENCE PREVENTION RESEARCH, EVALUATION, AND IMPLEMENTATION $6,293
93.866 AGING RESEARCH $6,257
93.865 CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH $4,061
93.110 SPECIAL PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $3,971
10.331 GUS SCHUMACHER NUTRITION INCENTIVE PROGRAM $3,764
93.387 NATIONAL AND STATE TOBACCO CONTROL PROGRAM $2,880
93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES $2,464
19.701 GLOBAL COUNTERTERRORISM PROGRAMS $208
93.226 RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES $-566
98.001 USAID FOREIGN ASSISTANCE FOR PROGRAMS OVERSEAS $-1,504
93.286 DISCOVERY AND APPLIED RESEARCH FOR TECHNOLOGICAL INNOVATIONS TO IMPROVE HUMAN HEALTH $-4,359
93.297 TEENAGE PREGNANCY PREVENTION PROGRAM $-9,536
93.826 CLOSING THE GAP BETWEEN STANDARDS DEVELOPMENT AND IMPLEMENTATION $-14,054
93.121 ORAL DISEASES AND DISORDERS RESEARCH $-19,499
93.321 DIETARY SUPPLEMENT RESEARCH PROGRAM $-43,515
93.103 FOOD AND DRUG ADMINISTRATION RESEARCH $-44,928
93.310 TRANS-NIH RESEARCH SUPPORT $-236,612